Smarter leaders trust GlobalData

Premium Insights India’s Mining Fiscal Regime: H2 2015

Buy the Report

According to GlobalData’s Technology Foresights, which uses over 443,000 patents to analyse innovation intensity for the healthcare industry, there are 200+ innovation areas that will shape the future of the industry.

Molecular diagnosis biomarkers is a key innovation area in genomics

Molecular biomarkers include biomolecules like nucleic acids and proteins that allow measurements in biological samples such as plasma, serum and cerebrospinal fluid. Diagnostic molecular biomarkers allow detection of a particular disease or disease subtype such as rapidly advancing cancer growth.

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.  According to GlobalData, there are 120+ companies, spanning technology vendors, established healthcare companies, and up-and-coming start-ups engaged in the development and application of molecular diagnosis biomarkers.

Key players in molecular diagnosis biomarkers – a disruptive innovation in the healthcare industry

‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.

‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Patent volumes related to molecular diagnosis biomarkers

Waters is one of the leading patent filers in the field of molecular diagnosis biomarkers. Some other key patent filers in the field include F. Hoffman-La Roche and Vanda Pharmaceuticals.

In terms of application diversity, Boston Medical Center leads the pack, followed by Lifecycle Technologies and Johnson & Johnson. By means of geographic reach, Iddex Laboratories holds the top position, followed by Cancer Prevention and Cure and Fetal Medicine Foundation in second and third spots, respectively.

Biological markers have a wide range of applications including early diagnosis of a disease, efficient treatment selection and monitoring the output of therapeutic treatments. Genomics used with biological markers will allow analysis of genetic variations to identify the risk of diseases and track the outcome of therapeutic interventions in patients that would improve the overall quality of patient treatment.

To further understand the key themes and technologies disrupting the healthcare industry, access GlobalData’s latest thematic research report on Healthcare.

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights. 

Sign up

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.

Share this article